EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Neptune Wellness Solutions EBITDA Margin % Related Terms
Neptune Wellness Solutions EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NEPTF vs CPMD, CLVR, THCT: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Neptune Wellness Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neptune Wellness Solutions EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Neptune Wellness Solutions's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Neptune Wellness Solutions's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neptune Wellness Solutions (NEPTF) has a EBITDA Margin % of -227.49% as of Dec. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Neptune Wellness Solutions and its competitors.
Is Neptune Wellness Solutions' EBITDA Margin % too high?
Neptune Wellness Solutions' current EBITDA Margin % is -227.49%. Overall, Neptune Wellness Solutions has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Neptune Wellness Solutions' EBITDA Margin % compare to CPMD and CLVR?
Neptune Wellness Solutions' EBITDA Margin % of -227.49% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Neptune Wellness Solutions and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neptune Wellness Solutions's current EBITDA Margin % is -227.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neptune Wellness Solutions stock overvalued right now?
Neptune Wellness Solutions (NEPTF) has a current EBITDA Margin % of -227.49%. The current EBITDA Margin % is -227.49%. Neptune Wellness Solutions' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Neptune Wellness Solutions (NEPTF), the current EBITDA Margin % is -227.49% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Neptune Wellness Solutions Inc is a consumer-packaged goods company that aims to innovate health and wellness products. It focuses on developing a portfolio of high-quality, affordable consumer products that align with the latest market trends for natural, sustainable, plant-based and purpose-driven lifestyle brands. The company's products include organic food and beverage brands such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. The company derives maximum revenue from United States.
16GF Score
Get the complete analysis for NEPTF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEPTF has been successfully added to your 
